REVIEW ARTICLE

전향적 감시 모델을 통한 림프부종 관리 체계의 임상적 적용

양은주 1 , *
Eun Joo Yang 1 , *
Author Information & Copyright ▼
1서울대학교 의과대학 재활의학교실
1Department of Rehabilitation Medicine, Seoul National University, Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
*Corresponding Author : Eun Joo Yang, MD, PhD, Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82, Gumi-ro 173beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 13620, Korea Tel: +82-31-787-7734, Fax: +82-31-787-4056, E-mail: graceloves@gmail.com

ⓒ Copyright 2016 Korean Society of Lymphology and Lymphedema. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Mar 21, 2016; Accepted: Apr 22, 2016

Published Online: Apr 30, 2016

Abatract

Breast cancer survivors are at increased risk for the development of breast cancer-related lymphedema (BCRL), a chronic, debilitating, and disfiguring condition that is progressive and requires lifelong self-management of symptoms. A prospective model for surveillance is necessary in order to detect BCRL at an early stage when there is the best chance to reduce risk or slow progression. Proper methods for monitoring and assessment of lymphedema, such as bioimpedance and circumferential arm measure or ultrasonography if necessary; prophylactic and early-intervention compression garments; progressive resistance exercise; and referral for complete decongestive therapy are the intervention to consider in the surveillance program. In addition, interactive engagement for symptom self-manegement should be implemented. We suggested our surveillance program for lymphedema management (SLYM).

Keywords: Lymphedema; Surveillance; Stage; Breast cancer